Collectively, the above findings make a strong case for DNMT inhibitors as a powerful tool for relieving MDSC-controlled immune suppression and the use of DNMT inhibitors to target MDSCs in infectious diseases holds great promise and warrants further investigation. Here, DNMT1 is linked to infectious disease.